(주)엔바이오스

{
  "address": "강원도 강릉시",
  "ceo_name": "이대희",
  "certificate": [
    {
      "cert_number": "20200111045",
      "changes": "",
      "disclosure_date": "2020-08-24",
      "first_cert_date": "2020-08-24",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-08-24 ~ 2022-08-23"
    },
    {
      "cert_number": "20220817010013",
      "changes": "",
      "disclosure_date": "2022-08-17",
      "first_cert_date": "2020-08-24",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2022-08-24 ~ 2025-08-23"
    },
    {
      "cert_number": "20250813010011",
      "changes": "",
      "disclosure_date": "2025-08-13",
      "first_cert_date": "2020-08-24",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2025-08-24 ~ 2028-08-23"
    }
  ],
  "company_name": "(주)엔바이오스",
  "corp_no": "141111-*******",
  "financials": {
    "2022": {
      "capital_stock": 81194000,
      "cost_of_sales": 0,
      "current_assets": 736611000,
      "current_liabilities": 131360000,
      "gross_profit": 49745000,
      "net_income": -377733000,
      "net_income_bs": -377733000,
      "non_current_assets": 380664000,
      "non_current_liabilities": 52900000,
      "non_operating_expenses": 25185000,
      "non_operating_income": 23590000,
      "operating_profit": -376138000,
      "revenue": 49745000,
      "sga_expenses": 425883000,
      "total_assets": 1117275000,
      "total_equity": 933015000,
      "total_liabilities": 184260000
    },
    "2023": {
      "capital_stock": 83322000,
      "cost_of_sales": 0,
      "current_assets": 321832000,
      "current_liabilities": 101089000,
      "gross_profit": 760168000,
      "net_income": -646631000,
      "net_income_bs": -646631000,
      "non_current_assets": 296395000,
      "non_current_liabilities": 31740000,
      "non_operating_expenses": 13531000,
      "non_operating_income": 29540000,
      "operating_profit": -662640000,
      "revenue": 760168000,
      "sga_expenses": 1422808000,
      "total_assets": 618227000,
      "total_equity": 485398000,
      "total_liabilities": 132829000
    },
    "2024": {
      "capital_stock": 83323000,
      "cost_of_sales": 11996000,
      "current_assets": 249701000,
      "current_liabilities": 165569000,
      "gross_profit": 607771000,
      "net_income": -104427000,
      "net_income_bs": -104427000,
      "non_current_assets": 627419000,
      "non_current_liabilities": 330580000,
      "non_operating_expenses": 8978000,
      "non_operating_income": 44722000,
      "operating_profit": -140171000,
      "revenue": 619767000,
      "sga_expenses": 747942000,
      "total_assets": 877120000,
      "total_equity": 380971000,
      "total_liabilities": 496149000
    }
  },
  "industry": "물리, 화학 및 생물학 연구개발업",
  "investment": [
    {
      "amount": "200,032,000",
      "changes": "200,032,000",
      "date": "2023-03-31"
    },
    {
      "amount": "250,000,000",
      "changes": "250,000,000",
      "date": "2021-03-05"
    },
    {
      "amount": "250,000,000",
      "changes": "250,000,000",
      "date": "2021-03-05"
    },
    {
      "amount": "249,000,000",
      "changes": "249,000,000",
      "date": "2021-02-23"
    }
  ],
  "main_products": "항암제 및 염증치료제",
  "phone": "033-640-****",
  "years": [
    2024,
    2023,
    2022
  ]
}